Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methylprednisolone 1mg/5ml oral suspension
0603020S0AAAEAE
|
Methylprednisolone | Methylprednisolone | Endocrine System | No data available |
|
Methylprednisolone sodium succinate 1g inj vials
0603020K0AAADAD
|
Methylprednisolone sodium succinate | Methylprednisolone sodium succinate | Endocrine System | No data available |
|
Methylprednisolone sodium succinate 2g inj vials
0603020K0AAAEAE
|
Methylprednisolone sodium succinate | Methylprednisolone sodium succinate | Endocrine System | No data available |
|
Methyltestosterone 10mg capsules
0604020H0AAAJAJ
|
Methyltestosterone | Methyltestosterone | Endocrine System | No data available |
|
Metreleptin 11.3mg powder for solution for injection vials
0607050A0AAACAC
|
Metreleptin | Metreleptin | Endocrine System | No data available |
|
Metreleptin 3mg powder for solution for injection vials
0607050A0AAAAAA
|
Metreleptin | Metreleptin | Endocrine System | No data available |
|
Metreleptin 5.8mg powder for solution for injection vials
0607050A0AAABAB
|
Metreleptin | Metreleptin | Endocrine System | No data available |
|
Metrodin High Purity 150unit inj ampoules
0605010M0BDACAD
|
Metrodin | Urofollitropin | Endocrine System | No data available |
|
Metrodin High Purity 75unit inj ampoules
0605010M0BDABAC
|
Metrodin | Urofollitropin | Endocrine System | No data available |
|
Metsol 500mg/5ml oral solution
0601022B0BHAAAR
|
Metsol | Metformin hydrochloride | Endocrine System | No data available |
|
Miacalcic 100units/1ml solution for injection ampoules
0606010T0BCABAA
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 200units/dose nasal spray
0606010T0BCAFAG
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 400units/2ml multidose inj vials
0606010T0BCACAB
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Miacalcic 50units/1ml solution for injection ampoules
0606010T0BCAAAC
|
Miacalcic | Calcitonin (Salmon) | Endocrine System | No data available |
|
Microdot testing strips
0601060D0CEAAA0
|
Microdot (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
Micronor HRT 1mg tablets
0604012P0BEAAAD
|
Micronor HRT | Norethisterone | Endocrine System | No data available |
|
Minirin 2.5micrograms/dose nasal spray
0605020E0BDABBP
|
Minirin | Desmopressin acetate | Endocrine System | No data available |
|
Minodiab 2.5mg tablets
0601021P0BCACAA
|
Minodiab | Glipizide | Endocrine System | No data available |
|
Mission Glucose testing strips
0601060U0BPAAA0
|
Mission (Reagent) | Urine testing reagents | Endocrine System | No data available |
|
Mission Ketone testing strips
0601060U0BPABA0
|
Mission (Reagent) | Urine testing reagents | Endocrine System | No data available |
|
Mixtard 10 NovoLet 100units/ml suspension for injection
0601012D0BCASBQ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 10 Penfill 100units/ml inj 3ml cartridges
0601012D0BCAYBI
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 20 NovoLet 100units/ml suspension for injection
0601012D0BCATA3
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 20 Penfill 100units/ml inj 3ml cartridges
0601012D0BCAZAZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 100units/ml suspension for injection 10ml vials
0601012D0BCAWAG
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.